Safety, Tolerability, Kinetics and Efficacy Study of Hoodia Gordonii Purified Extract (PYM50717)
NCT01306422 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2011-03-01
Summary
The objective of this clinical study was to assess the safety, tolerability, efficacy (effects on appetite scores, food intake) and plasma kinetics of Hoodia gordonii purified extract (H.g.PE), when consumed twice-daily for 2 or 15-days.
Conditions
- Appetite Depressant
- Overweight
- Body Weight
Interventions
- OTHER
-
Hoodia gordonii purified extract (H.g.PE)
H.g.PE(1110 mg) formulated yogurt drink, twice-daily, 65 minutes before breakfast and dinner, for 15 days
- OTHER
-
Placebo yogurt drink
Placebo product (yogurt drink matching the H.g.PE extract formulated yogurt drink in nutritional composition and taste. Placebo is consumed twice-daily, 65 minutes before breakfast and dinner for 15 days.
- OTHER
-
Placebo yogurt drink
Placebo product, twice-daily for two days, 65 minutes before breakfast and lunch
- OTHER
-
Placebo yogurt drink
Placebo product, twice-daily for two days, 65 minutes before breakfast and dinner
- OTHER
-
Hoodia gordonii purified extract (H.g.PE)
H.g.PE formulated product (1110 mg), twice-daily for two days, 65 minutes before breakfast and lunch
- OTHER
-
Hoodia gordonii purified extract (H.g.PE)
H.g.PE formulated product (1110 mg), twice-daily for two days, 65 minutes before breakfast and dinner
Sponsors & Collaborators
-
Phytopharm
collaborator INDUSTRY -
Covance
collaborator INDUSTRY -
Unilever R&D
lead INDUSTRY
Principal Investigators
-
Debra Mandarino, MD · Covance CRU, Madison WI
-
Leo Abrahamse, PhD · Unilever R&D Vlaardingen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-03-31
- Primary Completion
- 2008-07-31
- Completion
- 2008-10-31
Countries
- United States
Study Locations
More Related Trials
-
A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism
NCT02366156 ·Status: COMPLETED ·Phase: NA
-
Compare the Efficacy and Safety of Beta-Glucan as Add-On to Statin in Subjects With Hyperlipidemia.
NCT03857256 ·Status: COMPLETED ·Phase: PHASE2
-
HDL Function Dietary Supplement Safety and QOL
NCT04097119 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Study for Evaluating the Safety of Excessive Consumption of a Plant Sterol-enriched Yoghurt Drink
NCT01629888 ·Status: COMPLETED ·Phase: NA
-
Plant Sterols on Cardiovascular Markers, Microbiota and Sterol Metabolism (Cardiofoodsterol)
NCT06481020 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate Efficacy of Dietary Ingredient in Vitality and Metabolic Factors in Healthy Individuals
NCT06188949 ·Status: COMPLETED ·Phase: NA
-
LEAN Project: Weight Loss and Appetite Suppression
NCT00153790 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults
NCT03444298 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of 2 Different Broccoli Sprout Containing Supplements on Nasal Cells in Healthy Volunteers
NCT01129466 ·Status: COMPLETED ·Phase: NA
-
Yunzhi as Dietary Supplement in Breast Cancer
NCT00647075 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Ginko and Cistanche Against Fatigue Symptoms
NCT02807649 ·Status: COMPLETED ·Phase: NA
-
IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer
NCT00041223 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate Hyperlipidemia
NCT03550287 ·Status: COMPLETED ·Phase: PHASE4
-
Plant Stanols and Liver Inflammation in Overweight and Obese Children
NCT04783116 ·Status: UNKNOWN ·Phase: NA
-
Differential Effects of a Diet Supplementation With Plant Sterol Esters on Human Monocytes
NCT00928616 ·Status: UNKNOWN ·Phase: NA
-
Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled O3 Exposure
NCT02911688 ·Status: COMPLETED ·Phase: PHASE2
-
Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness
NCT07266571 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Oral Nutritional Supplement Effect on HDL Function
NCT04529174 ·Status: COMPLETED ·Phase: NA
-
Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled LPS
NCT02104505 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of a Combination of Plant Extracts (BSL_EP024) on the Immune Response
NCT04029558 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of a Single Dose of a Polyphenol-enriched Brown Seaweed Powder in Human
NCT00936754 ·Status: COMPLETED ·Phase: PHASE1
-
Cross-Over Broccoli Sprouts Trial
NCT01008826 ·Status: COMPLETED ·Phase: PHASE1
-
Investigations of Botanicals on Food Intake, Satiety, Weight Loss, and Oxidative Stress
NCT01238887 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Specialized Nutraceutical for Pre-burnout
NCT04532892 ·Status: COMPLETED ·Phase: NA
-
Dietary Histone Deacetylase Inhibitors (HDAC)
NCT01543074 ·Status: TERMINATED ·Phase: NA